Sign in
VINC Stock Price, Chart, Stats & News
Vincerx Pharma, Inc.
Save
Vincerx Pharma, Inc. (VINC) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
VINC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 50.00% |
Operating margin | -1868.26% |
Pretax margin | -1951.03% |
Net margin | -1951.03% |
Effective tax rate | – |
ROA | -444.66% |
ROE | -449.78% |
D/E | – |
Interest coverage ratio | – |
VINC valuation
P/E | – |
P/S | 0.06x |
P/B | 0.03x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.23x |
About
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U. S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer.
Similar securities
Based on sector and market capitalization
Report issue